Loyal’s big-dog lifespan drug clears third FDA hurdle
LOY-003, a daily tablet for large and giant breeds, has earned RXE acceptance, the third such milestone for…
Rejuvenate Bio secures funding and Merck partnership
New funds and strategic collaboration with Merck Animal Health will support development of therapies targeting age-related diseases in…
Bioengineered Implants Deliver Multi-Drug Therapy in Animal Models
Rice University PhD student Chris Wright holds the implant, which uses cells to manufacture pharmaceutical drugs beneath the…